On-Demand Version of the Implementation of Long-Acting Drugs for Treatment and Prevention of HIV is Now Available for Continuing Education Credits

This on-demand course includes an overview of the challenges in the implementation of long-acting drugs for the treatment and prevention of HIV and explore the latest research on the use of long-acting drugs for the treatment and prevention of HIV. Information are presented through a mix of didactic lectures, clinically relevant cases, and expert panel discussions developed and led by an expert faculty of HIV/AIDS clinicians and researchers.

Continuing Education Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this enduring material for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.